As per NPPA Order S.O. 5690(E) dated 17 October 2026, the trade margin on 137 non-scheduled anti-cancer medicines is capped at 30%. Hetero’s revised MRPs take effect on 9 November 2026.
Patients and partners with questions about the revised prices are welcome to speak to their doctor, pharmacist or hospital.
Source: NPPA Order S.O. 5690(E), The Gazette of India, 17 October 2026.
Oncology Division plays a key role in strengthening cancer treatment by offering a diverse range of oncology and haematology therapies. This division provides advanced pharmaceutical solutions that support the management of various cancers and blood-related disorders. By partnering with healthcare professionals and applying scientific advancements, the Hetero Oncology Division stay committed to improving cancer care and providing access to life-enhancing treatments.
View by-
